James William Burns
CIK: 0001900772
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AGIOS PHARMACEUTICALS, INC.
Discretionary Trading P&L
Holdings
Transaction History (29 total)
- Jun 18, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
Award(A)DirectRestricted stock units
3K shares- - Jun 18, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
Exercise(M)DirectPerformance share units
3K shares- - Apr 2, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
Exercise(M)Direct8.5K shares- - Apr 2, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
Sale(S)Direct3.3K shares at avg. $34.71$114K - Mar 2, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
Exercise(M)Direct4K shares- - Mar 2, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
Sale(S)Direct1.2K shares at avg. $28.96$34K - Mar 2, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
Exercise(M)Direct3.9K shares- - Mar 2, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
Sale(S)Direct1.2K shares at avg. $28.96$34K - Mar 2, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
Exercise(M)Direct5.7K shares- - Mar 2, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
Sale(S)Direct1.2K shares at avg. $28.96$34K - Mar 2, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
Exercise(M)Direct4K shares- - Mar 2, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
Sale(S)Direct1.7K shares at avg. $28.96$49K - Mar 1, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
Award(A)DirectStock options (right to buy)
52K shares- - Mar 1, 2026AGIO
AGIOS PHARMACEUTICALS, INC.
Award(A)DirectRestricted stock units
14K shares- - Dec 30, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
Exercise(M)Direct6K shares- - Dec 30, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
Sale(S)Direct2.9K shares at avg. $27.09$79K - Jun 24, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
Exercise(M)Direct6K shares- - Jun 24, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
Sale(S)Direct2.8K shares at avg. $33.54$94K - Mar 3, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
Sale(S)Direct1.7K shares at avg. $35.54$60K - Mar 3, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
Sale(S)Direct1.1K shares at avg. $35.54$40K - Mar 3, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
Sale(S)Direct1.2K shares at avg. $35.54$42K - Mar 1, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
Award(A)DirectStock options (right to buy)
43.5K shares- - Mar 1, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
Exercise(M)Direct5.7K shares- - Mar 1, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
Exercise(M)Direct3.8K shares- - Mar 1, 2025AGIO
AGIOS PHARMACEUTICALS, INC.
Award(A)DirectRestricted stock units
11.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 18, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Award(A) Restricted stock units | 3,000 | - | - | Direct |
| Jun 18, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise(M) Performance share units | 3,000 | - | - | Direct |
| Apr 2, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise(M) | 8,500 | - | $0 | Direct |
| Apr 2, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Sale(S) | 3,280 | $34.71 | $113,849 | Direct |
| Mar 2, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise(M) | 4,000 | - | $0 | Direct |
| Mar 2, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Sale(S) | 1,187 | $28.96 | $34,376 | Direct |
| Mar 2, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise(M) | 3,920 | - | $0 | Direct |
| Mar 2, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Sale(S) | 1,163 | $28.96 | $33,680 | Direct |
| Mar 2, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise(M) | 5,666 | - | $0 | Direct |
| Mar 2, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Sale(S) | 1,187 | $28.96 | $34,376 | Direct |
| Mar 2, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise(M) | 4,000 | - | $0 | Direct |
| Mar 2, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Sale(S) | 1,681 | $28.96 | $48,682 | Direct |
| Mar 1, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Award(A) Stock options (right to buy) | 52,000 | - | - | Direct |
| Mar 1, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | Award(A) Restricted stock units | 14,000 | - | - | Direct |
| Dec 30, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise(M) | 6,000 | - | $0 | Direct |
| Dec 30, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | Sale(S) | 2,932 | $27.09 | $79,428 | Direct |
| Jun 24, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise(M) | 6,000 | - | - | Direct |
| Jun 24, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | Sale(S) | 2,799 | $33.54 | $93,878 | Direct |
| Mar 3, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | Sale(S) | 1,681 | $35.54 | $59,743 | Direct |
| Mar 3, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | Sale(S) | 1,137 | $35.54 | $40,409 | Direct |
| Mar 3, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | Sale(S) | 1,187 | $35.54 | $42,186 | Direct |
| Mar 1, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | Award(A) Stock options (right to buy) | 43,500 | - | - | Direct |
| Mar 1, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise(M) | 5,667 | - | - | Direct |
| Mar 1, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | Exercise(M) | 3,833 | - | - | Direct |
| Mar 1, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | Award(A) Restricted stock units | 11,759 | - | - | Direct |
1-25 of 29 transactions
About Burns James William
Burns James William (SEC CIK 0001900772) files insider reports with the SEC as Chief Legal Officer of AGIOS PHARMACEUTICALS, INC. (AGIO).
Signal8 holds 7 ownership filings by Burns James William, all Form 4s, filed between Nov 12, 2024 and Jun 23, 2026. Those filings report 29 transactions, from Nov 7, 2024 to Jun 18, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Burns James William's filings is in CAMBRIDGE, MA.
Recent filings by Burns James William
- Jun 18, 2026: Grant or award of AGIO derivative securities (Form 4, code A).
- Jun 18, 2026: Option exercise of AGIO derivative securities (Form 4, code M).
- Apr 2, 2026: Option exercise of AGIO shares (Form 4, code M).
- Apr 2, 2026: Open-market sale of AGIO shares (Form 4, code S).
- Mar 2, 2026: Option exercise of AGIO shares (Form 4, code M).
Other insiders filing for AGIOS PHARMACEUTICALS, INC. (AGIO)
- Gheuens Sarah, Chief Medical Officer
- Backstrom Jay T., Director
- Ballal Rahul D., Director
- CAPELLO JEFFREY D, Director
- Foster-Cheek Kaye I, Director
- FOUSE JACQUALYN A, Director